197 related articles for article (PubMed ID: 16817776)
1. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response.
Isa MB; Martínez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV
Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.
Isa MB; Martínez L; Giordano M; Passeggi C; de Wolff MC; Nates S
Clin Diagn Lab Immunol; 2002 May; 9(3):693-7. PubMed ID: 11986279
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M antibody response to measles virus following natural virus infection, primary vaccination, and reexposure to the virus.
Nates S; Rey G; Giordano M; Medeot S; Depetris A; Boshell J; de Wolff CD
Viral Immunol; 1997; 10(3):165-73. PubMed ID: 9344339
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.
Toptygina AP; Pukhalsky AL; Alioshkin VA
Clin Diagn Lab Immunol; 2005 Jul; 12(7):845-7. PubMed ID: 16002633
[TBL] [Abstract][Full Text] [Related]
5. HHV-6 IgG4 isotype response following measles infection.
Ferreyra L; Bustos D; Biganzoli P; Isa MB; Don PS; Ribechini E; Nates SV; Pavan JV
J Med Virol; 2010 Mar; 82(3):396-9. PubMed ID: 20087929
[TBL] [Abstract][Full Text] [Related]
6. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
8. Measles virus-specific immunoglobulin G isotype immune response in early and late infections.
Isa MB; Martínez L; Giordano M; Zapata M; Passeggi C; De Wolff MC; Nates S
J Clin Microbiol; 2001 Jan; 39(1):170-4. PubMed ID: 11136766
[TBL] [Abstract][Full Text] [Related]
9. Measles immunity and response to revaccination of a young adult population in Israel.
Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
11. [Peculiarity of the laboratory diagnostic of the measles virus infection in previously vaccinated and unvaccinated patients].
Mamaeva TA; Lipskaia GIu; Naumova MA; Shul'ga SV; Mulders M; Featherstone DA; Zav'ialova LA; Chernysheva EV; Zamiatina EP; Kuznetsova NN
Vopr Virusol; 2012; 57(5):21-6. PubMed ID: 23248855
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
Wong-Chew RM; Beeler JA; Audet S; Santos JI
J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
[TBL] [Abstract][Full Text] [Related]
13. Measles immunity and response to revaccination among secondary school children in Cumbria.
Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
[TBL] [Abstract][Full Text] [Related]
14. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.
Vardas E; Kreis S
J Clin Virol; 1999 Aug; 13(3):173-9. PubMed ID: 10443793
[TBL] [Abstract][Full Text] [Related]
15. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
[TBL] [Abstract][Full Text] [Related]
16. Measles virus-specific cellular immunity in patients with vaccine failure.
Wu VH; McFarland H; Mayo K; Hanger L; Griffin DE; Dhib-Jalbut S
J Clin Microbiol; 1993 Jan; 31(1):118-22. PubMed ID: 8417015
[TBL] [Abstract][Full Text] [Related]
17. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
18. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.
El Mubarak HS; Ibrahim SA; Vos HW; Mukhtar MM; Mustafa OA; Wild TF; Osterhaus AD; de Swart RL
J Med Virol; 2004 Feb; 72(2):290-8. PubMed ID: 14695672
[TBL] [Abstract][Full Text] [Related]
19. [Study on the immunization effect of measles vaccine by capture-EIA].
Fang H
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
